Jordan Brian K, Schilling Diane, McEvoy Cindy T
Department of Pediatrics, Division of Neonatology, Oregon Health & Science University, Portland, OR.
Department of Pediatrics, Division of Neonatology, Oregon Health & Science University, Portland, OR.
J Pediatr. 2017 Feb;181:62-66.e1. doi: 10.1016/j.jpeds.2016.10.022. Epub 2016 Nov 7.
To compare the pulmonary function, measured at birth and at hospital discharge, of infants whose mothers had been randomized to a single rescue course of antenatal steroids versus those whose mothers had been randomized to placebo.
This study involved follow-up at hospital discharge of subjects of a randomized, double-blinded trial. In the original trial, pregnant women at ≥14 days after their initial course of antenatal steroids and <34 weeks' gestation were randomized to rescue antenatal steroids (44 mothers, 56 infants) or placebo (41 mothers, 57 infants). Passive respiratory compliance (Crs), passive respiratory resistance, and functional residual capacity were measured in all infants at birth and again at discharge to evaluate changes in pulmonary mechanics over time. Statistical analyses were based on intention to treat.
We previously reported that compared with infants in the placebo group, infants in the rescue antenatal steroids group had a higher mean Crs value measured within 72 hours of birth (1.21 vs 1.01 mL/cm HO/kg; P < .05). Here we show that the Crs benefit in the antenatal steroids group was sustained until discharge. Infants in the placebo group demonstrated improvement in Crs such that by discharge, there was no difference in mean Crs between the rescue antenatal steroids and placebo groups (1.18 vs 1.22 mL/cm HO/kg).
Rescue antenatal steroids significantly increased Crs measured within 72 hours of birth, and this increase was sustained until hospital discharge. Preterm infants in the placebo group demonstrated a decreased initial Crs compared with the rescue antenatal steroids group, but achieved a comparable Crs by the time of discharge.
ClinicalTrials.gov: NCT00669383.
比较母亲被随机分配接受单剂产前类固醇抢救疗程的婴儿与母亲被随机分配接受安慰剂的婴儿在出生时和出院时的肺功能。
本研究涉及对一项随机双盲试验受试者出院时的随访。在原试验中,在首次产前类固醇疗程后≥14天且妊娠<34周的孕妇被随机分配接受产前类固醇抢救(44名母亲,56名婴儿)或安慰剂(41名母亲,57名婴儿)。在所有婴儿出生时和出院时测量被动呼吸顺应性(Crs)、被动呼吸阻力和功能残气量,以评估肺力学随时间的变化。统计分析基于意向性治疗。
我们之前报告过,与安慰剂组的婴儿相比,产前类固醇抢救组的婴儿在出生后72小时内测得的平均Crs值更高(1.21 vs 1.01 mL/cm H₂O/kg;P<0.05)。在此我们表明,产前类固醇组的Crs益处持续到出院。安慰剂组的婴儿Crs有所改善,以至于到出院时,产前类固醇抢救组和安慰剂组之间的平均Crs没有差异(1.18 vs 1.22 mL/cm H₂O/kg)。
产前类固醇抢救显著增加了出生后72小时内测得的Crs,且这种增加持续到出院。与产前类固醇抢救组相比,安慰剂组的早产儿初始Crs较低,但到出院时达到了相当的Crs。
ClinicalTrials.gov:NCT00669383。